시장보고서
상품코드
1042904

세계의 근시 및 노안 치료 시장 : 근시 치료 종류별(교정, 외과 수술), 노안 치료 종류별(렌즈 처방, 콘택트렌즈), 지역별 시장 규모, 점유율 및 동향 분석, 부문별 예측(2021-2028년)

Myopia And Presbyopia Treatment Market Size, Share & Trends Analysis Report By Myopia Treatment Type (Corrective, Surgical, Drugs), By Presbyopia Treatment Type, By Region, And Segment Forecasts, 2022 - 2030

발행일: | 리서치사: Grand View Research, Inc. | 페이지 정보: 영문 110 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 근시 및 노안 치료 시장 규모는 2021-2028년간 7.9%의 CAGR로 확대되고, 2028년에 280억 달러에 달할 것으로 예상됩니다.

대상이 되는 질환의 연구개발이 활발해지고 있는 점이 예측기간 중 시장을 크게 견인할 것으로 생각됩니다. 또한 근시나 고도 근시 유병률 증가가 예측기간 중 시장을 지지할 것으로 예상됩니다. 일본, 중국, 싱가포르, 한국 등 아시아태평양의 개발도상국에서는 최근 근시 이환율이 빠르게 증가하고 있습니다. Statista에 의하면 세계의 근시 환자수는 향후 10년간 28% 증가하고, 고도 근시의 경우는 30% 증가할 것으로 예상됩니다.

근시나 노안 증가는 업계 관계자에게 있어서 효율적인 치료 솔루션을 도입하는 기회가 되고 있습니다. 선진국 중에서도 미국은 특히 42세 이상의 근시·노안 발증률이 크게 상승하고 있습니다. 선진국에서는 기술적으로 우수한 수술 방법이 도입되고, 높은 보급률을 나타내고 있어 향후 몇 년간 시장 성장이 전망됩니다.

세계의 근시 및 노안 치료(Myopia And Presbyopia Treatment) 시장에 대해 조사 분석했으며, 시장 및 업계 전망, 부문별·지역별 시장 전망 등, 경쟁 상황에 대한 체계적인 정보를 제공합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 근시 및 노안 치료 시장 변수, 동향 및 범위

  • 시장 계통 전망
  • 침투와 성장 전망 매핑
  • 업계의 밸류체인 분석
  • 시장 역학
  • 근시 및 노안 치료 시장 분석 툴

제4장 근시 치료 종류별 시장 추정과 동향 분석

  • 정의와 범위
    • 교정
    • 외과 수술
    • 약물
  • 근시 치료 종류별 시장 점유율, 2020년 및 2028년
  • 부문 대시보드
  • 근시 치료 종류 전망별 세계의 근시 및 노안 치료 시장
  • 시장 규모와 예측 및 동향 분석, 2018-2028년
    • 교정
    • 외과 수술
    • 약물

제5장 노안 치료 종류별 시장 추정과 동향 분석

  • 정의와 범위
    • 렌즈 처방
    • 콘택트렌즈
    • 안내 렌즈
    • 굴절교정 수술
  • 노안 치료 종류별 시장 점유율, 2020년 및 2028년
  • 부문 대시보드
  • 노안 치료 종류 전망별 세계의 근시 및 노안 치료 시장
  • 시장 규모와 예측 및 동향 분석, 2018-2028년
    • 렌즈 처방
    • 콘택트렌즈
    • 안내 렌즈
    • 굴절교정 수술

제6장 근시와 노안 치료 : 지역별 시장 추정과 동향 분석

  • 지역 시장 점유율 분석, 2020년 및 2028년
  • 지역별 시장 대시보드
  • 세계의 지역 시장 현황
  • 지역 시장 점유율과 주요 기업, 2018년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 요인별 SWOT 분석(정치적 및 법적, 경제적 및 기술적)
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 규모 및 예측, 볼륨 및 동향 분석, 2018-2028년
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 스웨덴
    • 러시아
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 터키
    • 아랍에미리트

제7장 경쟁 상황

  • 시장 참여 주요 기업별 최신 동향 및 영향 분석
  • 기업/경쟁 분류
  • 벤더 상황
KSM 22.01.05

Myopia And Presbyopia Treatment Market Growth & Trends:

The global myopia and presbyopia treatment market size is expected to reach USD 33.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2022 to 2030. Growing research and development in the targeted disorders is expected to drive the market considerably over the forecast period. Moreover, the growing prevalence of myopia and high myopia is anticipated to fuel the market growth during the forecast period. Incidences of myopia in the developing countries of Asia Pacific, such as Japan, China, Singapore, and the Republic of Korea, are growing steeply in recent years.

The growing prevalence of myopia and presbyopia is an opportunity for industry players to introduce efficient treatment solutions. Among the developed nations, the U.S. is witnessing a significant boost in the incidence of myopia and presbyopia, especially in individuals over 42 years of age. The introduction of technologically advanced surgical options and high adoption rates in developed countries are expected to boost the market growth in the upcoming years.

Advanced diagnostic and surgical treatment solutions include LASIK, LASEK, and PRK. The integration of these techniques with artificial intelligence and robot-assisted surgical tools is expected to fuel the number of surgical procedures. The introduction of multifocal intraocular lenses and implantable contact lenses is expected to have a positive impact on the market growth.

Myopia And Presbyopia Treatment Market Report Highlights:

  • By myopia treatment type, single prescription corrective lenses held a significant share in the market in 2021 owing to the progression of myopia with age, thus requiring frequent changes of corrective lenses
  • Based on presbyopia treatment type, the progressive multifocals segment is expected to grow significantly over the forecast period owing to the wide acceptance due to aesthetic advantages
  • Multifocal contact lenses for the correction of presbyopia held the second-largest share in 2021 largely due to the easy availability and effective outcomes
  • North America was the leading regional market in 2021 due to the rising demand for myopia and presbyopia contact lenses for vision correction
  • The Asia Pacific region is anticipated to expand at the fastest growth rate during the forecast period due to the rising incidence of ophthalmic diseases and the growing geriatric population across several countries in Asia

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Regional
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Myopia and Presbyopia Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
    • 3.4.2. Market restraint analysis
    • 3.4.3. Industry challenges
  • 3.5. Myopia and Presbyopia Treatment Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Myopia Treatment Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Corrective
      • 4.1.1.1. Prescription Lenses
      • 4.1.1.1.1. Single
      • 4.1.1.1.2. Bifocal
      • 4.1.1.1.3. Trifocal
      • 4.1.1.1.4. Others
      • 4.1.1.2. Contact Lenses
    • 4.1.2. Surgical
    • 4.1.3. Drugs
  • 4.2. Myopia Treatment Type Market Share, 2021 and 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Myopia and Presbyopia Treatment Market by Myopia Treatment Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 4.5.1. Corrective
      • 4.5.1.1. Prescription Lenses
      • 4.5.1.1.1. Single
      • 4.5.1.1.2. Bifocal
      • 4.5.1.1.3. Trifocal
      • 4.5.1.1.4. Others
      • 4.5.1.2. Contact Lenses
    • 4.5.2. Surgical
    • 4.5.3. Drugs

Chapter 5. Presbyopia Treatment Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Prescription Lenses
      • 5.1.1.1. Reading Glasses
      • 5.1.1.2. Bifocals
      • 5.1.1.3. Trifocals
      • 5.1.1.4. Progressive Multifocals
      • 5.1.1.5. Office Progressives
    • 5.1.2. Contact Lenses
      • 5.1.2.1. Bifocal
      • 5.1.2.2. Multifocal
      • 5.1.2.3. Monovison
      • 5.1.2.4. Modified Monovision
    • 5.1.3. Intraocular Lenses
    • 5.1.4. Refractive Surgery
  • 5.2. Presbyopia Treatment Type Market Share, 2021 and 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Myopia and Presbyopia Treatment Market by Presbyopia Treatment Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 5.5.1. Prescription Lenses
      • 5.5.1.1. Reading Glasses
      • 5.5.1.2. Bifocals
      • 5.5.1.3. Trifocals
      • 5.5.1.4. Progressive Multifocals
      • 5.5.1.5. Office Progressives
    • 5.5.2. Contact Lenses
      • 5.5.2.1. Bifocal
      • 5.5.2.2. Multifocal
      • 5.5.2.3. Monovison
      • 5.5.2.4. Modified Monovision
    • 5.5.3. Intraocular Lenses
    • 5.5.4. Refractive Surgery

Chapter 6. Myopia and Presbyopia Treatment: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2021 and 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2021
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.7.2. U.S.
      • 6.7.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.7.3. Canada
      • 6.7.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. U.K.
      • 6.8.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.8.2. Germany
      • 6.8.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.8.3. France
      • 6.8.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.8.4. Italy
      • 6.8.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.8.5. Spain
      • 6.8.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Japan
      • 6.9.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.9.2. China
      • 6.9.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.9.3. India
      • 6.9.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.9.4. Thailand
      • 6.9.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.9.5. South Korea
      • 6.9.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 6.10. Latin America
    • 6.10.1. Brazil
      • 6.10.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.10.2. Mexico
      • 6.10.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.10.3. Argentina
      • 6.10.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.10.4. Colombia
      • 6.10.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 6.11. MEA
    • 6.11.1. South Africa
      • 6.11.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.11.2. Saudi Arabia
      • 6.11.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 6.11.3. UAE
      • 6.11.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. 8.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. 8.2 Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. 8.3 Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2021
    • 7.3.4. Zeimer Ophthalmic Systems AG
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. NIDEK CO. LTD.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Johnson & Johnson Vision
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. ZEISS International
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. ALCON VISION LLC
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Bausch & Lomb Incorporated
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Haag-Streit UK
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Topcon Corporation
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Essilor Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제